BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12622426)

  • 1. Expression of cyclooxygenase-2 protein in colorectal carcinomas.
    Joo YE; Kim HS; Min SW; Lee WS; Park CH; Park CS; Choi SK; Rew JS; Kim SJ
    Int J Gastrointest Cancer; 2002; 31(1-3):147-54. PubMed ID: 12622426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclooxygenase-1 and -2 and clinicopathologic features of colorectal cancer in northern Thailand.
    Sankhasard S; Lertprasertsuk N; Vinitketkumnuen U; Cressey R
    Asian Pac J Cancer Prev; 2004; 5(1):44-9. PubMed ID: 15075004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between COX-2 expression and clinicopathological features of colorectal cancers.
    Zhan J; Liu JP; Zhu ZH; Yao HR; Chen CY
    Chin Med J (Engl); 2004 Aug; 117(8):1151-4. PubMed ID: 15361286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer.
    Tomozawa S; Tsuno NH; Sunami E; Hatano K; Kitayama J; Osada T; Saito S; Tsuruo T; Shibata Y; Nagawa H
    Br J Cancer; 2000 Aug; 83(3):324-8. PubMed ID: 10917546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between cyclooxygenase-2 expression and colorectal cancer.
    Sheehan KM; Sheahan K; O'Donoghue DP; MacSweeney F; Conroy RM; Fitzgerald DJ; Murray FE
    JAMA; 1999 Oct; 282(13):1254-7. PubMed ID: 10517428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic importance of COX-2 expression in patients with colorectal cancer.
    Yamac D; Celenkoglu G; Coskun U; Akyurek N; Akcali Z; Dursun A; Koybasioglu F
    Pathol Res Pract; 2005; 201(7):497-502. PubMed ID: 16164044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
    Hastürk S; Kemp B; Kalapurakal SK; Kurie JM; Hong WK; Lee JS
    Cancer; 2002 Feb; 94(4):1023-31. PubMed ID: 11920472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
    Shattuck-Brandt RL; Lamps LW; Heppner Goss KJ; DuBois RN; Matrisian LM
    Mol Carcinog; 1999 Mar; 24(3):177-87. PubMed ID: 10204802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer.
    Zhang H; Sun XF
    Am J Gastroenterol; 2002 Apr; 97(4):1037-41. PubMed ID: 12003384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 expression in oral squamous cell carcinoma.
    Pannone G; Bufo P; Caiaffa MF; Serpico R; Lanza A; Lo Muzio L; Rubini C; Staibano S; Petruzzi M; De Benedictis M; Tursi A; De Rosa G; Macchia L
    Int J Immunopathol Pharmacol; 2004; 17(3):273-82. PubMed ID: 15461861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
    Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
    Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis.
    Joo YE; Oh WT; Rew JS; Park CS; Choi SK; Kim SJ
    Digestion; 2002; 66(4):222-9. PubMed ID: 12592098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of COX-2 in stomach cancers and its relation to their biological features.
    Han SL; Tang HJ; Hua YW; Ji SQ; Lin DX
    Dig Surg; 2003; 20(2):107-14. PubMed ID: 12686777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients.
    Masunaga R; Kohno H; Dhar DK; Ohno S; Shibakita M; Kinugasa S; Yoshimura H; Tachibana M; Kubota H; Nagasue N
    Clin Cancer Res; 2000 Oct; 6(10):4064-8. PubMed ID: 11051257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
    Zhan J; Tang XD
    Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of COX-2 immunohistochemical expression evaluated by quantitative image analysis in colorectal cancer.
    Zafirellis K; Agrogiannis G; Zachaki A
    APMIS; 2008 Oct; 116(10):912-22. PubMed ID: 19132985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant overexpression of cyclooxygenase-2 in HER-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome.
    Okano H; Shinohara H; Miyamoto A; Takaori K; Tanigawa N
    Clin Cancer Res; 2004 Oct; 10(20):6938-45. PubMed ID: 15501972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder.
    Shirahama T; Arima J; Akiba S; Sakakura C
    Cancer; 2001 Jul; 92(1):188-93. PubMed ID: 11443626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High cyclooxygenase-2 expression is related with distant metastasis in cervical cancer treated with radiotherapy.
    Kim HJ; Wu HG; Park IA; Ha SW
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):16-20. PubMed ID: 12504031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients' prognosis.
    Wu AW; Gu J; Ji JF; Li ZF; Xu GW
    World J Gastroenterol; 2003 Sep; 9(9):1990-4. PubMed ID: 12970891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.